PER-003-00已完成未知
EOADYUVANTE PHASE 2 STUDY USING GEMCITABIN ASSOCIATED WITH DOXORRUBICINE FOR THE TREATMENT OF BREAST CANCER CLINICAL STAGE III-B
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
PHASE II TRIAL OF THE COMBINATION OF GEMCITABINE AND OXALIPLATIN IN THE TREATMENT OF PATIENTS WITH METASTATIC ADENOCARCINOMA OF UNKNOWN PRIMARY SITEEstudio fase II de la combinación de gemcitabina y oxaliplatino en el tratamiento de pacientes con adenocarcinoma matastático de origen desconocido.EUCTR2005-001912-38-ESACROSS43
进行中（未招募）
1 期
PHASE II STUDY OF BENDAMUSTINE, GEMCITABINE AND VINORELBINE AS INDUCTION THERAPY IN HODGKIN’S LYMPHOMA FAILING PRIOR ANTITUMOR TREATMENT, BEFORE HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELLS TRANSPLANTpatients with relapsed-refractory Hodgkin's LymphomaMedDRA version: 14.1Level: PTClassification code 10020266Term: Hodgkin's disease recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10020267Term: Hodgkin's disease refractorySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-022169-91-ITISTITUTO CLINICO HUMANITAS59
进行中（未招募）
不适用
A PHASE II STUDY OF THE COMBINATION OF GEMCITABINE AND IMATINIB MESYLATE IN PRETREATED PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMAMalignant Pleural MesotheliomaEUCTR2014-002876-10-ITIstituto Clinico Humanitas
进行中（未招募）
1 期
PHASE II TRIAL OF THE EFFECT OF GEMCITABINE WITH INTRAVENOUS OMEGA 3 FISH OIL INFUSION IN PATIENTS WITH UNRESECTABLE PANCREATIC ADENOCARCINOMA. - FISH OIL AND GEMCITABINE IN PANCREATIC ADENOCARCINOMA - VERSION 1EUCTR2009-009470-27-GBniversity Hospitals of Leicester NHS Trust50
已完成
不适用
PHASE II STUDY: COMBINATION OF GEMCITABIN WITH CARBOPLATIN IN PATIENTS WITH REFERENCED OR RECURRENT ADVANCED EPITHELIAL OVARY CANCER-C56 Malignant neoplasm of ovaryMalignant neoplasm of ovaryC56PER-080-02ELI LILLY INTERAMERICA INC.,